This Article Full Text Full Text (PDF) All Versions of this Article: 0008-5472.CAN-08-3515v1 69/5/1885    most recent Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Tworoger, S. S. Articles by Hankinson, S. E. Search for Related Content PubMed PubMed Citation Articles by Tworoger, S. S. Articles by Hankinson, S. E.

Polymorphisms in the Vitamin D Receptor and Risk of Ovarian Cancer in Four Studies

¹ Channing Laboratory and ² Division of Preventive Medicine, Department of Medicine, ³ Department of Obstetrics and Gynecology, Brigham and Women's Hospital; ⁴ Department of Epidemiology, Harvard School of Public Health, Boston, Massachusetts; and ⁵ Departments of Community and Family Medicine and Pediatrics, Dartmouth Medical School and the Norris Cotton Cancer Center, Lebanon, New Hampshire

Requests for reprints: Shelley S. Tworoger, Channing Laboratory, 181 Longwood Avenue, 3rd Floor, Boston, MA 02115. Phone: 617-525-2087; Fax: 617-525-2008; E-mail: nhsst{at}channing.harvard.edu.

Key Words: Vitamin D • ovarian cancer • prospective

Prior studies have suggested that vitamin D may reduce ovarian cancer risk. Thus, we examined whether three single nucleotide polymorphisms (SNP) in the vitamin D receptor (VDR) gene (Fok1, Bsm1, Cdx2) were associated with risk of epithelial ovarian cancer in a retrospective case-control study (New England Case-Control study, NECC) and a nested case-control study of three prospective cohort studies: the Nurses' Health Study (NHS), NHSII, and the Women's Health Study. Data from the cohort studies were combined and analyzed using conditional logistic regression and pooled with the results from the NECC, which were analyzed using unconditional logistic regression, using a random effects model. We obtained genotype data for 1,473 cases and 2,006 controls. We observed a significant positive association between the number of Fok1 f alleles and ovarian cancer risk in the pooled analysis (P_trend = 0.03). The odds ratio (OR) for the ff versus FF genotype was 1.26 [95% confidence interval (CI) = 1.01–1.57]. Neither the Bsm1 (P_trend = 0.96) or Cdx2 (P_trend = 0.13) SNPs were significantly associated with ovarian cancer risk. Among the prospective studies, the risk of ovarian cancer by plasma vitamin D levels did not clearly vary by any of the genotypes. For example, among women with the Fok1 FF genotype, the OR comparing plasma 25-hydroxyvitamin D 32 ng/mL versus <32 ng/mL was 0.66 (95% CI, 0.34–1.28), and among women with the Ff or ff genotype the OR was 0.71 (95% CI, 0.43–1.18). Our results of an association with the Fok1 VDR polymorphism further support a role of the vitamin D pathway in ovarian carcinogenesis. [Cancer Res 2009;69(5):1885–91]

This article has been cited by other articles:

				W. B Grant On the roles of skin type and sun exposure in the risk of endometriosis and melanoma Int. J. Epidemiol., November 3, 2009; (2009) dyp324v1. [Full Text] [PDF]

				M. Kvaskoff, S. Mesrine, F. Clavel-Chapelon, and M.-C. Boutron-Ruault Author's Response * On the roles of skin type and sun exposure in the risk of endometriosis and melanoma Int. J. Epidemiol., November 3, 2009; (2009) dyp326v1. [Full Text] [PDF]

				Correction: Article on VDR Polymorphisms and Ovarian Cancer Cancer Res., June 15, 2009; 69(12): 5267 - 5267. [Full Text] [PDF]